The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Merck and Moderna reported Phase 3 data from the INTerpath-001 trial in resected high-risk melanoma, where personalized mRNA ...
Moderna (NASDAQ:MRNA) stock is in focus as cancer-vaccine optimism and a pending Nasdaq-100 addition anchor the mRNA developer's healthcare headlines today.
Moderna's Binance Futures contract (MRNA) is trading at $223.28 as of November 2, 2026, up 1.56% on the session and holding ...
Hello everyone. Kato-chan here.Do you all remember the previous report published around August 20th, "The Corona Darling ...
The results, which triggered Moderna’s stock to drop, are “really encouraging,” says Karen Knudsen, CEO of the Parker ...
Moderna’s cancer vaccine data cut recurrence risk 42%, but valuation looks full. Click for more on MRNA stock.
The Phase 3 INTerpath-001 trial delivered oncology's first personalised cancer vaccine win, and mRNA a therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results